+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastric Cancer (Oncology) - Drugs In Development, 2021

  • ID: 5438150
  • Report
  • August 2021
  • Region: Global
  • 3373 Pages
  • Global Markets Direct
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 3SBio Inc
  • BioAtla Inc
  • EirGenix Inc
  • ImmunityBio Inc
  • Mirati Therapeutics Inc
  • Scancell Holdings Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide 'Gastric Cancer - Drugs In Development, 2021', provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights


This report provides comprehensive information on the therapeutics under development for Gastric Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 23, 180, 223, 5, 26, 202, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 12, 10, 1, 1, 9 and 3 molecules, respectively.

Gastric Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Gastric Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Gastric Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Gastric Cancer (Oncology)

Reasons to Buy


  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Gastric Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Gastric Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3SBio Inc
  • BioAtla Inc
  • EirGenix Inc
  • ImmunityBio Inc
  • Mirati Therapeutics Inc
  • Scancell Holdings Plc
Introduction

Gastric Cancer - Overview

Gastric Cancer - Therapeutics Development

Gastric Cancer - Therapeutics Assessment

Gastric Cancer - Companies Involved in Therapeutics Development

Gastric Cancer - Drug Profiles

Gastric Cancer - Dormant Projects

Gastric Cancer - Discontinued Products

Gastric Cancer - Product Development Milestones

Appendix

List of Tables
  • Number of Products under Development for Gastric Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Gastric Cancer - Pipeline by 3SBio Inc, 2021
  • Gastric Cancer - Pipeline by AbbVie Inc, 2021
  • Gastric Cancer - Pipeline by Abclon Inc, 2021
  • Gastric Cancer - Pipeline by Abion Inc, 2021
  • Gastric Cancer - Pipeline by ABL Bio Inc, 2021
  • Gastric Cancer - Pipeline by Abpro Corp, 2021
  • Gastric Cancer - Pipeline by AbTis Co Ltd, 2021
  • Gastric Cancer - Pipeline by Accurus Biosciences Inc, 2021
  • Gastric Cancer - Pipeline by Acrotech Biopharma LLC, 2021
  • Gastric Cancer - Pipeline by AD Pharmaceuticals Co Ltd, 2021
  • Gastric Cancer - Pipeline by Adaptimmune Therapeutics Plc, 2021
  • Gastric Cancer - Pipeline by ADC Therapeutics SA, 2021
  • Gastric Cancer - Pipeline by Advenchen Laboratories LLC, 2021
  • Gastric Cancer - Pipeline by Affimed GmbH, 2021
  • Gastric Cancer - Pipeline by AffyImmune Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Agenus Inc, 2021
  • Gastric Cancer - Pipeline by AIMM Therapeutics BV, 2021
  • Gastric Cancer - Pipeline by Akeso Inc, 2021
  • Gastric Cancer - Pipeline by Alkermes Plc, 2021
  • Gastric Cancer - Pipeline by Alligator Bioscience AB, 2021
  • Gastric Cancer - Pipeline by Alphamab Oncology, 2021
  • Gastric Cancer - Pipeline by Alteogen Inc, 2021
  • Gastric Cancer - Pipeline by AltruBio Inc, 2021
  • Gastric Cancer - Pipeline by ALX Oncology Holdings Inc, 2021
  • Gastric Cancer - Pipeline by Ambrx Biopharma Inc, 2021
  • Gastric Cancer - Pipeline by amcure GmbH, 2021
  • Gastric Cancer - Pipeline by Amgen Inc, 2021
  • Gastric Cancer - Pipeline by Andes Biotechnologies, 2021
  • Gastric Cancer - Pipeline by Anew Oncology Inc, 2021
  • Gastric Cancer - Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, 2021
  • Gastric Cancer - Pipeline by Antikor Biopharma Ltd, 2021
  • Gastric Cancer - Pipeline by Apollomics Inc, 2021
  • Gastric Cancer - Pipeline by Apotex Inc, 2021
  • Gastric Cancer - Pipeline by Aprea Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Arbele Ltd, 2021
  • Gastric Cancer - Pipeline by Arcus Biosciences Inc, 2021
  • Gastric Cancer - Pipeline by Argonaut Therapeutics Ltd, 2021
  • Gastric Cancer - Pipeline by Arog Pharmaceuticals Inc, 2021
  • Gastric Cancer - Pipeline by Arromax Pharmatech Co Ltd, 2021
  • Gastric Cancer - Pipeline by Aryogen Pharmed, 2021
  • Gastric Cancer - Pipeline by Immunicum AB, 2021
  • Gastric Cancer - Pipeline by Immunisbio Co Ltd, 2021
  • Gastric Cancer - Pipeline by ImmunityBio Inc, 2021
  • Gastric Cancer - Pipeline by Immunocore Holdings Plc, 2021
  • Gastric Cancer - Pipeline by Immunomet Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Immunomic Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Immunotech Biopharm Ltd, 2021
  • Gastric Cancer - Pipeline by Imugene Ltd, 2021
  • Gastric Cancer - Pipeline by Incyte Corp, 2021
  • Gastric Cancer - Pipeline by Inhibrx Inc, 2021
  • Gastric Cancer - Pipeline by Inner Mongolia Qite Biotechnology (Group) Co Ltd, 2021
  • Gastric Cancer - Pipeline by Innovative Cellular Therapeutics Co Ltd, 2021
  • Gastric Cancer - Pipeline by Innovent Biologics Inc, 2021
  • Gastric Cancer - Pipeline by Inovio Pharmaceuticals Inc, 2021
  • Gastric Cancer - Pipeline by Intocell Inc, 2021
  • Gastric Cancer - Pipeline by Intra-Immusg Pvt Ltd, 2021
  • Gastric Cancer - Pipeline by InxMed Shanghai Co Ltd, 2021
  • Gastric Cancer - Pipeline by Ipsen SA, 2021
  • Gastric Cancer - Pipeline by Istari Oncology Inc, 2021
  • Gastric Cancer - Pipeline by Ithax Pharmaceuticals Inc, 2021
  • Gastric Cancer - Pipeline by JenKem Technology Co Ltd, 2021
  • Gastric Cancer - Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, 2021
  • Gastric Cancer - Pipeline by Jiangsu Atom Bioscience and Pharmaceutical Co Ltd, 2021
  • Gastric Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
  • Gastric Cancer - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, 2021
  • Gastric Cancer - Pipeline by Jina Pharmaceuticals Inc, 2021
  • Gastric Cancer - Pipeline by Jiuzhitang Co Ltd, 2021
  • Gastric Cancer - Pipeline by Johnson & Johnson, 2021
  • Gastric Cancer - Pipeline by Joint Biosciences Ltd, 2021
  • Gastric Cancer - Pipeline by Jounce Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by JW Pharmaceutical Corp, 2021
  • Gastric Cancer - Pipeline by Karyo Biologics LLC, 2021
  • Gastric Cancer - Pipeline by Karyopharm Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by KeyMed Biosciences Inc, 2021
  • Gastric Cancer - Pipeline by Keythera Pharmaceuticals Co Ltd, 2021
  • Gastric Cancer - Pipeline by Kintor Pharmaceutical Ltd, 2021
  • Gastric Cancer - Pipeline by KLUS Pharma Inc, 2021
  • Gastric Cancer - Pipeline by Komipharm International Co Ltd, 2021
  • Gastric Cancer - Pipeline by Kringle Pharma Inc, 2021
  • Gastric Cancer - Pipeline by Kupffer Biotherapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Kymab Ltd, 2021
  • Gastric Cancer - Pipeline by Kyowa Kirin Co Ltd, 2021
  • Gastric Cancer - Pipeline by LaNova Medicines Ltd, 2021
  • Gastric Cancer - Pipeline by LATITUDE Pharmaceuticals Inc, 2021
  • Gastric Cancer - Pipeline by Lead Discovery Center GmbH, 2021
  • Gastric Cancer - Pipeline by Leap Therapeutics Inc, 2021
  • Gastric Cancer - Pipeline by Turnstone Biologics Inc, 2021
  • Gastric Cancer - Pipeline by Tvardi Therapeutics Inc, 2021

List of Figures
  • Number of Products under Development for Gastric Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3SBio Inc
  • AbbVie Inc
  • Abclon Inc
  • Abion Inc
  • ABL Bio Inc
  • Abpro Corp
  • AbTis Co Ltd
  • Accurus Biosciences Inc
  • Acrotech Biopharma LLC
  • AD Pharmaceuticals Co Ltd
  • Adaptimmune Therapeutics Plc
  • ADC Therapeutics SA
  • Advenchen Laboratories LLC
  • Affimed GmbH
  • AffyImmune Therapeutics Inc
  • Agenus Inc
  • AIMM Therapeutics BV
  • Akeso Inc
  • Alkermes Plc
  • Alligator Bioscience AB
  • Alphamab Oncology
  • Alteogen Inc
  • AltruBio Inc
  • ALX Oncology Holdings Inc
  • Ambrx Biopharma Inc
  • amcure GmbH
  • Amgen Inc
  • Andes Biotechnologies
  • Anew Oncology Inc
  • Anhui Anke Biotechnology (Group) Co Ltd
  • Antikor Biopharma Ltd
  • Apollomics Inc
  • Apotex Inc
  • Aprea Therapeutics Inc
  • Arbele Ltd
  • Arcus Biosciences Inc
  • Argonaut Therapeutics Ltd
  • Arog Pharmaceuticals Inc
  • Arromax Pharmatech Co Ltd
  • Aryogen Pharmed
  • Asana BioSciences LLC
  • Ascelia Pharma AB
  • Ascenta Therapeutics Inc
  • Ascentage Pharma Group International
  • AskAt Inc
  • Aslan Pharmaceuticals Ltd
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Atara Biotherapeutics Inc
  • Aurigene Discovery Technologies Ltd
  • Aurora BioPharma Inc
  • Avvinity Therapeutics Ltd
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • Beijing BGI-GBI Biotech Co Ltd
  • Beijing Biostar Technologies Ltd
  • Beijing Combio Pharmaceuticals Ltd
  • Beijing Hanmi Pharmaceutical Co Ltd
  • Beijing Immunochina Pharmaceuticals Co Ltd
  • Beijing Konruns Pharmaceutical Co Ltd
  • Beijing Mabworks Biotech Co Ltd
  • Beijing Scitech-MQ Pharmaceuticals Ltd
  • Beijing Shenzhou Cell Biotechnology Group Co Ltd
  • Beijing Syngentech Co Ltd
  • Bellicum Pharmaceuticals Inc
  • Benhealth Biopharmaceutical (Shenzhen) Co Ltd
  • Betta Pharmaceuticals Co Ltd
  • Bicara Therapeutics Inc
  • Bicycle Therapeutics Plc
  • Bika Biotechnology Guanzhou Co Ltd
  • Bio-Synectics Inc
  • Bio-Thera Solutions Ltd
  • BioAtla Inc
  • BioEclipse Therapeutics Inc
  • BioIntegrator Ltd
  • BioLineRx Ltd
  • Biomunex Pharmaceuticals
  • BioNTech SE
  • Biosion Inc
  • BioSplice Therapeutics Inc
  • BioSyngen Pte Ltd
  • Biotecnol Ltd
  • BJ Bioscience Inc
  • Black Diamond Therapeutics Inc
  • Bliss Biopharmaceutical (Hangzhou) Co Ltd
  • Blueprint Medicines Corp
  • Boehringer Ingelheim International GmbH
  • Bold Therapeutics Inc
  • Bolt Biotherapeutics Inc
  • BrickBio Inc
  • BridgeBio Pharma Inc
  • Bristol-Myers Squibb Co
  • Byondis BV
  • Calico Life Sciences LLC
  • CalyGene Biotechnology Inc
  • CanBas Co Ltd
  • Cancer Prevention Pharmaceuticals Inc
  • Cannabics Pharmaceuticals Inc
  • Carisma Therapeutics Inc
  • CARsgen Therapeutics Ltd
  • CAS-Lamvac Biotech Co Ltd
  • Catalent Inc
  • Celldex Therapeutics Inc
  • Cellestia Biotech AG
  • Cellid Co Ltd
  • Cellivery Therapeutics Inc
  • Cello Therapeutics Inc
  • Celon Pharma SA
  • Celularity Inc
  • Cend Therapeutics Inc
  • Centrymed Pharmaceutical Inc
  • Checkmate Pharmaceuticals Inc
  • Chengdu Jinrui Foundation Biotechnology Co Ltd
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd
  • Chia Tai Tianqing Pharmaceutical Group Co Ltd
  • China Immunotech (Beijing) Biotechnology Co Ltd
  • Chong Kun Dang Pharmaceutical Corp
  • Chugai Pharmaceutical Co Ltd
  • Cloaked Therapeutics LLC
  • CMG Pharmaceutical Co Ltd
  • Coherent Biopharma
  • Conagen Inc
  • Constellation Pharmaceuticals Inc
  • Convalife
  • CSPC Pharmaceutical Group Ltd
  • CStone Pharmaceuticals Co Ltd
  • Cumberland Pharmaceuticals Inc
  • Curegenix Inc
  • CureLab Oncology Inc
  • CureMeta LLC
  • Cynvec LLC
  • Cytocom Inc
  • Cytodyn Inc
  • CytoImmune Therapeutics Inc
  • CytoMed Therapeutics Pte Ltd
  • CytomX Therapeutics Inc
  • Daiichi Sankyo Co Ltd
  • Defence Therapeutics Inc
  • Delta-Fly Pharma Inc
  • DiNonA Inc
  • DM Bio Ltd
  • DNAtrix Inc
  • Dongguan Daxin Biotechnology Co Ltd
  • Dragonfly Therapeutics Inc
  • Dyadic International Inc
  • Eddingpharm Inc
  • Eden Biologics Inc
  • eFFECTOR Therapeutics Inc
  • EirGenix Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Ella Therapeutics Ltd
  • Elucida Oncology Inc
  • EOS Biosciences Inc
  • EpimAb Biotherapeutics Inc
  • EpiThany Inc
  • Epsilogen Ltd
  • ERYTECH Pharma SA
  • Esperance Pharmaceuticals Inc
  • eTheRNA Immunotherapies NV
  • Eutilex Co Ltd
  • Excelmab Inc
  • Exelixis Inc
  • EXUMA Biotech Inc
  • F-star Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • Fate Therapeutics Inc
  • Frost Biologic Inc
  • FutureGen Biopharm Technology Co Ltd
  • G+FLAS Life Sciences Inc
  • GAiA BioMedicine Inc
  • Galecto Inc
  • GC Pharma
  • GEMoaB Monoclonals GmbH
  • Geneius Biotechnology Inc
  • Genentech USA Inc
  • GeneQuantum Healthcare Suzhou Co Ltd
  • GeneScience Pharmaceuticals Co Ltd
  • Genexine Inc
  • Genmab AS
  • GenoImmune Therapeutics Biotechnology Co Ltd
  • Genome & Co
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • GLG Pharma SA
  • GlycoNex Inc
  • Glycotope GmbH
  • Gossamer Bio Inc
  • Green Cross LabCell Corp
  • Grid Therapeutics LLC
  • Guangdong Yinzhu Pharmaceutical Technology Co Ltd
  • Guangdong Zhongsheng Pharmaceutical Co Ltd
  • Guangzhou BeBetter Medicine Technology Co Ltd
  • Haikou Qili Pharmaceutical Co Ltd
  • HaimBio Ltd
  • Hainan Kaibo Biotechnology Co Ltd
  • Hangzhou Bensheng Pharmaceutical Co Ltd
  • Hangzhou DAC Biotech Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Harbour BioMed (Guangzhou) Co Ltd
  • Helixmith Co Ltd
  • Hengenix Biotech Inc
  • HengRui YuanZheng Bio-Technology Co Ltd
  • Hibercell Inc
  • Highlight Therapeutics SL
  • HitGen Inc
  • Hope Biosciences Inc
  • Horizon Therapeutics Plc
  • Huabo Biopharm (Shanghai) Co Ltd
  • Huadao Shanghai Biomedical Co Ltd
  • Hummingbird Bioscience Pte Ltd
  • Hutchison MediPharma Ltd
  • I-Mab
  • Ichnos Sciences Inc
  • Ideaya Biosciences Inc
  • Idience Co Ltd
  • IGM Biosciences Inc
  • ImCheck Therapeutics SAS
  • ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Immunicum AB
  • Immunisbio Co Ltd
  • ImmunityBio Inc
  • Immunocore Holdings Plc
  • Immunomet Therapeutics Inc
  • Immunomic Therapeutics Inc
  • Immunotech Biopharm Ltd
  • Imugene Ltd
  • Incyte Corp
  • Inhibrx Inc
  • Inner Mongolia Qite Biotechnology (Group) Co Ltd
  • Innovative Cellular Therapeutics Co Ltd
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • Intocell Inc
  • Intra-Immusg Pvt Ltd
  • InxMed Shanghai Co Ltd
  • Ipsen SA
  • Istari Oncology Inc
  • Ithax Pharmaceuticals Inc
  • JenKem Technology Co Ltd
  • Jiangsu Aosaikang Pharmaceutical Co Ltd
  • Jiangsu Atom Bioscience and Pharmaceutical Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Jina Pharmaceuticals Inc
  • Jiuzhitang Co Ltd
  • Johnson & Johnson
  • Joint Biosciences Ltd
  • Jounce Therapeutics Inc
  • JW Pharmaceutical Corp
  • Karyo Biologics LLC
  • Karyopharm Therapeutics Inc
  • KeyMed Biosciences Inc
  • Keythera Pharmaceuticals Co Ltd
  • Kintor Pharmaceutical Ltd
  • KLUS Pharma Inc
  • Komipharm International Co Ltd
  • Kringle Pharma Inc
  • Kupffer Biotherapeutics Inc
  • Kymab Ltd
  • Kyowa Kirin Co Ltd
  • LaNova Medicines Ltd
  • LATITUDE Pharmaceuticals Inc
  • Lead Discovery Center GmbH
  • Leap Therapeutics Inc
  • Legend Biotech Corp
  • LegoChem Biosciences Inc
  • Lepu Biopharma Co Ltd
  • Leukocare AG
  • Liminatus Pharma LLC
  • LintonPharm Co Ltd
  • LipoMedix Pharmaceutical Inc
  • Livzon Pharmaceutical Group Co Ltd
  • Luye Pharma Group Ltd
  • Lycera Corp
  • Lytix Biopharma AS
  • Mabpharm Ltd
  • MacroGenics Inc
  • MaxiVAX SA
  • MBQ Pharma Inc
  • Mecox Cure Med Co Ltd
  • MedAbome Inc
  • Meditope Biosciences Inc
  • MedPacto Inc
  • Merck & Co Inc
  • Merck KGaA
  • Mereo Biopharma Group Plc
  • Merus NV
  • Metagone Biotech Inc
  • Metis Precision Medicine
  • Midissia Therapeutics Inc
  • Millennium Pharmaceuticals Inc
  • Mirati Therapeutics Inc
  • Mitsubishi Tanabe Pharma Corp
  • Moderna Inc
  • Molecular Partners AG
  • Molecular Templates Inc
  • Moleculin Biotech Inc
  • Morphogenesis Inc
  • Multitude therapeutics Inc
  • Mustang Bio Inc
  • Mycenax Biotech Inc
  • Myeloid Therapeutics Inc
  • Nanjing Bioheng Biotech Co Ltd
  • Nanjing CART Medical Technology Co Ltd
  • Nanjing Iaso Biotherapeutics Co Ltd
  • Nanjing Tianyi Bioscience Co Ltd
  • Nanjing Transthera Biosciences Co Ltd
  • NanoCarrier Co Ltd
  • NanoMab Technology Ltd
  • NeuClone Pty Ltd
  • NewBio Therapeutics Inc
  • NextCure Inc
  • NGM Biopharmaceuticals Inc
  • Nouscom AG
  • NovaRock Biotherapeutics Inc
  • Novartis AG
  • Novonco Pharmaceuticals Inc
  • OBI Pharma Inc
  • Ocellaris Pharma Inc
  • Ona Therapeutics SL
  • OncoC4 Inc
  • Oncolys BioPharma Inc
  • Onconic Therapeutics Co Ltd
  • OncoSynergy Inc
  • OncoTherapy Science Inc
  • OncXerna Therapeutics Inc
  • Ono Pharmaceutical Co Ltd
  • Onxeo SA
  • Opsona Therapeutics Ltd
  • Orano Med LLC
  • Origincell Technology Group Co Ltd
  • Oxford BioTherapeutics Ltd
  • Parasol Biotech Co Ltd
  • Patrys Ltd
  • PersonGen Biomedicine Suzhou Co Ltd
  • Pfizer Inc
  • Phanes Therapeutics Inc
  • Pharma Mar SA
  • Pharmapraxis
  • Philogen SpA
  • Phosplatin Therapeutics LLC
  • Pieris Pharmaceuticals Inc
  • Pionyr Immunotherapeutics Inc
  • PlantForm Corp
  • Plus Therapeutics Inc
  • PNB Vesper Life Science Pvt Ltd
  • Precirix NV
  • Prescient Therapeutics Ltd
  • Prestige BioPharma Ltd
  • Protheragen Inc
  • Puma Biotechnology Inc
  • Qilu Pharmaceutical Co Ltd
  • Qilu Puget Sound Biotherapeutics Corp
  • Quadriga BioSciences Inc
  • QureBio Ltd
  • Rakuten Medical Inc
  • RAPT Therapeutics Inc
  • RaQualia Pharma Inc
  • Redx Pharma Plc
  • Relay Therapeutics Inc
  • RemeGen Co Ltd
  • Rhizen Pharmaceuticals SA
  • Rongchang Pharmaceuticals Ltd
  • RUS Pharmtech
  • S.Biomedics Co Ltd
  • Samyang Biopharmaceuticals Corp
  • Sanofi
  • Scancell Holdings Plc
  • Seagen Inc
  • SELLAS Life Sciences Group Inc
  • Seven and Eight Biopharmaceuticals Corp
  • Shandong Boan Biotechnology Co Ltd
  • Shandong Golden Brick Biotechnology Co Ltd
  • Shanghai Biomed-Union Biotechnology Co Ltd
  • Shanghai Bioray Laboratory Inc
  • Shanghai GeneChem Co Ltd
  • Shanghai Haihe Biopharma Co Ltd
  • Shanghai Henlius Biotech Inc
  • Shanghai icell Biotechnology Co Ltd
  • Shanghai Junshi Bioscience Co Ltd
  • Shanghai Keqi Pharmaceutical Technology Co Ltd
  • Shanghai Longyao Biotechnology Co Ltd
  • Shanghai Miracogen Inc
  • Shanghai PerHum Therapeutics Co Ltd
  • Shanghai Pharmaceutical Group Co Ltd
  • Shanghai Sunstem Biotechnology Co Ltd
  • Shanghai Xunhe Pharmaceutical Technology Co Ltd
  • Shanghai Yihao Biotechnology Co Ltd
  • Shaperon Inc
  • Shenogen Pharma Group Ltd
  • Shenyang Dongxing Pharmaceutical Co Ltd
  • Shenzhen BinDeBio Ltd
  • Shenzhen Chipscreen Biosciences Co Ltd
  • Shenzhen Fapon Biopharma Inc
  • Shenzhen Hornetcorn Bio-technology Company Ltd
  • Shenzhen NeoCura Biotechnology Corp
  • Shijiazhuang No. 4 Pharmaceutical Co Ltd
  • Shijiazhuang Sagacity New Drug Development Co Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Silicon Therapeutics LLC
  • Sillajen Biotherapeutics
  • Silverback Therapeutics Inc
  • Simcha Therapeutics Inc
  • Sino Biopharmaceutical Ltd
  • SN BioScience
  • Sorrento Therapeutics Inc
  • Sotio AS
  • Sparx Therapeutics Inc
  • ST Pharm Co Ltd
  • Stcube Inc
  • Stemirna Therapeutics Ltd
  • Sumitomo Dainippon Pharma Co Ltd
  • Suntec Medical (Taiwan) Inc
  • Surface Oncology Inc
  • Suzhou Maximum Bio-tech Co Ltd
  • Suzhou Sinovent Pharmaceuticals Co Ltd
  • Suzhou Zanrong Pharmaceutical Technology Co Ltd
  • Suzhou Zelgen Biopharmaceutical Co Ltd
  • Symphogen A/S
  • SynCore Biotechnology Co Ltd
  • SynOx Therapeutics Ltd
  • Systimmune Inc
  • T-Cure Bioscience Inc
  • Tachyon Therapeutics Inc
  • TAE Life Sciences LLC
  • Taiho Oncology Inc
  • Taiho Pharmaceutical Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Takis Srl
  • Tarus Therapeutics Inc
  • Tarveda Therapeutics Inc
  • Tasly Pharmaceutical Group Co Ltd
  • Teclison Ltd
  • TempestTx, Inc.
  • Tessa Therapeutics Ltd
  • Themis Bioscience GmbH
  • Tonix Pharmaceuticals Holding Corp
  • Toray Industries Inc
  • TOT Biopharm Co Ltd
  • Transcenta Holding Ltd
  • Transcode Therapeutics Inc
  • Treos Bio Ltd
  • Trio Medicines Ltd
  • Turning Point Therapeutics Inc
  • Turnstone Biologics Inc
  • Tvardi Therapeutics Inc
  • Tyg Oncology Ltd
  • Ube Industries Ltd
  • UCB SA
  • United BioPharma Inc
  • United Immunity Co Ltd
  • VacV Biotherapeutics Ltd
  • Vaxon Biotech
  • Vedanta Biosciences Inc
  • Venus Remedies Ltd
  • Viracta Therapeutics Inc
  • Viralytics Pty Ltd
  • VM Discovery Inc
  • Wellington Zhaotai Therapies Ltd
  • WellMarker Bio Co Ltd
  • Wuhan YZY Biopharma Co Ltd
  • Xcovery Holding Co LLC
  • Xencor Inc
  • Xiangxue Life Sciences
  • XuanZhu Biological Technology Co Ltd
  • Zai Lab Ltd
  • Zhejiang Doer Biologics Corp
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Zhejiang Jianfeng Group Company Ltd
  • Zymeworks Inc
Note: Product cover images may vary from those shown